Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00716872
Other study ID # 13685
Secondary ID
Status Completed
Phase N/A
First received June 18, 2008
Last updated February 24, 2010
Start date July 2008
Est. completion date November 2009

Study information

Verified date February 2010
Source University of Virginia
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.


Description:

The purpose of this study is to test the feasibility of using an Internet program to improve the sleep of cancer patients with insomnia. Participants will receive access to the Internet program (called SHUTi, or "Shut-Eye") as well as to self-hypnosis recordings designed to improve sleep. SHUTi provides an online, tailored educational program to individuals who are experiencing sleep difficulties, including those having difficulty falling asleep, waking in the middle of the night, and waking too early in the morning.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date November 2009
Est. primary completion date November 2009
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Age = At least 21 years old

- Regular access to the Internet, including e-mail

- Cancer patient

- Any type of cancer (EXCEPT non-melanoma skin cancer)

- In remission from any stage of cancer (active treatment completed at least one month prior to enrollment)

- Insomnia diagnosis (combined from DSM-IV and ICSD):

- Subjective complaints of poor sleep for at least 6 months

- Sleep difficulties =3 nights/week

- Difficulty falling asleep (=30 minutes to fall asleep) OR

- Difficulty staying asleep (=30 minutes awake in the middle of the night)

- =6.5 hours sleep/night

- Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance)

- Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment

Exclusion Criteria:

- Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias)

- Having a medical condition other than cancer that causes insomnia

- Experiencing a psychiatric disturbance (major depression, psychosis)

- Experiencing substance abuse

- Currently undergoing psychotherapy or counseling

- Changing sleep/anxiety/depression medication within the past month

- Having an "unusual" sleep pattern

- Normal bedtime is after 2am OR

- Normal wake time is after 9am

- Working as a shift worker (that is, having a schedule that requires working through the night)

- Participants reports that she is pregnant or intending to get pregnant in the next 4 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Sleep Healthy Using the Internet (SHUTi)
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I). Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information. As they progress through the program, users receive tailored instructions for how to improve their sleep.
Hypnosis recordings
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.

Locations

Country Name City State
United States University of Virginia Department of Psychiatry & Neurobehavioral Sciences Charlottesville Virginia

Sponsors (1)

Lead Sponsor Collaborator
University of Virginia

Country where clinical trial is conducted

United States, 

References & Publications (1)

Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005 Sep 1;23(25):6083-96. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Insomnia Severity Index (ISI) prior to intervention, after SHUTi use, after Hypnosis use No
Primary Sleep Diary: Sleep Efficiency prior to intervention, after SHUTi use, after Hypnosis use No
Primary Sleep Diary: Total Sleep Time prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Sleep Diary: Sleep Onset Latency (SOL) prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Sleep Diary: Wake After Sleep Onset (WASO) prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Sleep Diary: Number of Nighttime Awakenings prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Hospital Depression and Anxiety Scale prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Pain scale prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Multidimensional Fatigue Symptom Inventory prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Quality of Life (SF-12 Health Survey) prior to intervention, after SHUTi use, after Hypnosis use No
Secondary Hot flashes prior to intervention, after SHUTi use, after Hypnosis use No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients